Rates of discontinuation and non-publication of trials for the pharmacologic treatment of alcohol use disorder

References

• APA. Diagnostic and Statistical Manual of Mental Disorders (DSM-5^®). Washington DC: American Psychiatric Association; 2013.
   Google Scholar
• SAMHSA. 2019 National Survey on Drug Use and Health (NSDUH). SAMHSA; 2019. https://www.samhsa.gov/data/sites/default/files/reports/rpt29394/NSDUHDetailedTabs2019/NSDUHDetTabsSec.Accessed December 3, 2020.
   Google Scholar
• Weiss RD, O'malley SS, Hosking JD, LoCastro JS, Swift R. COMBINE study research group. do patients with alcohol dependence respond to placebo? Results from the COMBINE Study. J Stud Alcohol Drugs. 2008;69(6):878–884.
   PubMed Web of Science ®Google Scholar
• Witkiewitz K, Litten RZ, Leggio L. Advances in the science and treatment of alcohol use disorder. Sci Adv. 2019;5(9):eaax4043.
   PubMed Web of Science ®Google Scholar
• Yardley MM, Ray LA. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol. 2017;22(3):581–615.
   PubMed Web of Science ®Google Scholar
• Johnson AL, Fladie I, Anderson JM, Lewis DM, Mons BR, Vassar M. Rates of discontinuation and nonpublication of head and neck cancer randomized clinical trials. JAMA Otolaryngol Head Neck Surg. 2020;146(2):176–182.
   PubMed Web of Science ®Google Scholar
• Yilmaz T, Jutten RJ, Santos CY, Hernandez KA, Snyder PJ. Discontinuation and nonpublication of interventional clinical trials conducted in patients with mild cognitive impairment and Alzheimer’s disease. Alzheimer’s Dement. 2018;4(1):161–164.
   Google Scholar
• Khan MS, Shahid I, Asad N. Discontinuation and non-publication of heart failure randomized controlled trials: a call to publish all trial results. ESC Heart Failure. https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.13099. Published online 2020.
   Google Scholar
• Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Obstet Gynecol. 2009;114(6):1341–1345.
   PubMed Web of Science ®Google Scholar
• Briel M, Olu KK, von Elm E, et al. A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable. J Clin Epidemiol. 2016;80:8–15.
   PubMed Web of Science ®Google Scholar
• WHO. WHO statement on public disclosure of clinical trial results. https://www.who.int/ictrp/results/reporting/en/. Published online March 13, 2017. Accessed December 6, 2020.
   Google Scholar
• FDA. FDA’s Role: ClinicalTrials.gov information; 2020. https://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/fdas-role-clinicaltrialsgov-information. Published December 2, 2020. Accessed December 6, 2020.
   Google Scholar
• Center for Drug Evaluation & Research. Alcoholism: Developing Drugs for Treatment. FDA; 2015. Accessed October 18, 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/alcoholism-developing-drugs-treatment.
   Google Scholar
• Falk DE, O’Malley SS, Witkiewitz K, for the Alcohol Clinical Trials Initiative (ACTIVE) Workgroup, et al. Evaluation of drinking risk levels as outcomes in alcohol pharmacotherapy trials: a secondary analysis of 3 randomized clinical trials. JAMA Psychiatry. 2019;76(4):374.
   PubMed Web of Science ®Google Scholar
• Witkiewitz K, Bowen S. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. J Consult Clin Psychol. 2010;78(3):362–374.
   PubMed Web of Science ®Google Scholar
• Wetherill RR, Spilka N, Jagannathan K, et al. Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial. Neuropsychopharmacol. 2021;46(8):1414–1420.
   PubMed Web of Science ®Google Scholar
• Humphreys K, Harris AHS, Weingardt KR. Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. J Stud Alcohol Drugs. 2008;69(5):757–764.
   PubMed Web of Science ®Google Scholar
• Humphreys K, Weingardt KR, Horst D, Joshi AA, Finney JW. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970–98. Addiction. 2005;100(9):1249–1257.
   PubMed Web of Science ®Google Scholar
• Finlay AK, Ellerbe LS, Wong JJ, et al. Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs. J Subst Abuse Treat. 2017;77:38–43.
   PubMed Web of Science ®Google Scholar
• Hoertel N, Falissard B, Humphreys K, Gorwood P, Seigneurie A-S, Limosin F. Do clinical trials of treatment of alcohol dependence adequately enroll participants with co-occurring independent mood and anxiety disorders? An analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2014;75(3):231–237.
   PubMed Web of Science ®Google Scholar
• Anderson A, Borfitz D, Getz K. Global public attitudes about clinical research and patient experiences with clinical trials. JAMA Netw Open. 2018;1(6):e182969.
   PubMed Web of Science ®Google Scholar
• NIAAA. Current research in medications development. NIAAA; 2020. https://www.niaaa.nih.gov/major-initiatives/medications-development-program/current-research-medications-development. Accessed December 7, 2020.
   Google Scholar
• NCT01254877. Ondansetron, alcohol use, and alcohol-related symptoms in HIV+ persons; 2020. https://clinicaltrials.gov/ct2/show/results/NCT01254877. Accessed December 8, 2020.
   Google Scholar
• Schwandt ML, Diazgranados N, Umhau JC, Kwako LE, George DT, Heilig M. PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study. Psychopharmacology. 2020;237(8):2367–2380.
   PubMed Web of Science ®Google Scholar
• Knapp CM, Ciraulo DA, Sarid-Segal O, et al. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders. J Clin Psychopharmacol. 2015;35(1):34–42.
   PubMed Web of Science ®Google Scholar
• Ioannidis JPA, Greenland S, Hlatky MA, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383(9912):166–175.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Ohlsson H, Sundquist J, Sundquist K. Alcohol use disorder and mortality across the lifespan: a longitudinal cohort and co-relative analysis. JAMA Psychiatry. 2016;73(6):575–581.
   PubMed Web of Science ®Google Scholar
• Song F, Loke Y, Hooper L. Why are medical and health-related studies not being published? A systematic review of reasons given by investigators. PLOS One. 2014;9(10):e110418.
   PubMed Web of Science ®Google Scholar
• Olson CM, Rennie D, Cook D, et al. Publication bias in editorial decision making. JAMA. 2002;287(21):2825–2828.
   PubMed Web of Science ®Google Scholar
• Fanelli D. Do pressures to publish increase scientists' bias? An empirical support from US states data. PLOS One. 2010;5(4):e10271.
   PubMed Web of Science ®Google Scholar
• Dirnagl U, Lauritzen M. Fighting publication bias: introducing the negative results section. J Cereb Blood Flow Metab. 2010;30(7):1263–1264.
   PubMed Web of Science ®Google Scholar
• Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics. 2012;90(3):891–904.
   Web of Science ®Google Scholar
• Mulimani P. Publication bias towards Western populations harms humanity. Nat Hum Behav. 2019;3(10):1026–1027.
   PubMed Web of Science ®Google Scholar
• Patel V, Sumathipala A. International representation in psychiatric literature: survey of six leading journals. Br J Psychiatry. 2001;178:406–409.
   PubMed Web of Science ®Google Scholar
• Chalmers I, Glasziou P, Godlee F. All trials must be registered and the results published. BMJ. 2013;346:f105.
   Google Scholar
• Schmucker C, Schell LK, Portalupi S, OPEN consortium, et al. Extent of non-publication in cohorts of studies approved by research ethics committees or included in trial registries. PLOS One. 2014;9(12):e114023.
   PubMed Web of Science ®Google Scholar
• Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ. 2013;347:f6104.
   PubMed Web of Science ®Google Scholar
• Bleijenberg N, de Man-van Ginkel JM, Trappenburg JCA, et al. Increasing value and reducing waste by optimizing the development of complex interventions: enriching the development phase of the Medical Research Council (MRC) framework. Int J Nurs Stud. 2018;79:86–93.
   PubMed Web of Science ®Google Scholar
• Tse T, Fain KM, Zarin DA. How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider. BMJ. 2018;361:k1452.
   PubMedGoogle Scholar
• Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med. 2015;372(11):1031–1039.
   PubMed Web of Science ®Google Scholar
• Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP. Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol. 2006;59(7):697–703.
   PubMed Web of Science ®Google Scholar
• Mbuagbaw L, Lawson DO, Puljak L, Allison DB, Thabane L. A tutorial on methodological studies: the what, when, how and why. BMC Med Res Methodol. 2020;20(1):226.
   PubMed Web of Science ®Google Scholar
• Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10:ED000142.
   PubMed Web of Science ®Google Scholar